NCT02498613 2025-09-25A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting122 enrolled 16 charts
NCT00544674 2012-12-10PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung CancerProacta, IncorporatedPhase 2 Terminated5 enrolled 7 charts